3rd Quarter - Report

THE D MAJOR GROUP for EMD SERONO, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Monitor issues concerning "march-in" rights as related to pharmaceutical research and development.

LobbyistCovered position, as disclosed
DIANE MAJOR Health Policy Analyst for Senate Republican Policy Committee
BRENDA REESE Conference Coordinator for House Republican Conference

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Monitor provisions related to federal price negotiation, Part D redesign and excise tax as included in H.R. 5376, the "Inflation Reduction Act." Also work on HR 19 and S. 2164, the Lower Costs More Cures Act.

LobbyistCovered position, as disclosed
DIANE MAJOR Health Policy Analyst for Senate Republican Policy Committee
BRENDA REESE Conference Coordinator for House Republican Conference

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th), S. 2164 (117th), H.R. 19 (117th)

Pharmacy PHA

Monitor FDA User Fee Reauthorization measures as included in HR 6833, the "Continuing Appropriations & Ukraine Supplemental Appropriations Act."

LobbyistCovered position, as disclosed
DIANE MAJOR Health Policy Analyst for Senate Repub. Policy Com't.
BRENDA REESE Conference Coordinator for House Republican Conf.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6833 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.